|
Mike Henos is the founder and Managing General Partner of Alliance Technology Ventures. He focuses on investments in biotechnology and personalized medicine. Mike has successfully invested in several private companies which have gone on to become public corporations. Among these investments are Adeza Biomedical, Amylin Pharmaceuticals, AtheroGenics, Inhibitex, Keravision, Ligand Pharmaceuticals, and RF Micro Devices. Mr. Henos is presently Chairman of the Board of AtheroGenics and Inhibitex, both based in Alpharetta, Georgia. He currently serves as a director of ATV portfolio companies Genoptix, GlycoMimetics, Neuronyx, Sensys Medical and ValuBond. He also is responsible for ATV's investment in Aderis Pharmaceuticals. | 